Answers are grounded in this paper and cite their sources.
Systematic review demonstrates potential efficacy of deferiprone in slowing Parkinson's symptoms, indicating a need for further trials.
Deferiprone shows potential in slowing motor symptom progression in Parkinson's disease, although its impact on brain iron levels remains inconclusive. Further large-scale, long-term studies are warranted to establish its clinical efficacy and safety.
No takes yet. Share an insight, caveat, or question.
Alla et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: